Tim Walbert, Horizon Therapeutics CEO (via YouTube)

Hori­zon Ther­a­peu­tics in takeover talks with Am­gen, J&J, Sanofi as po­ten­tial buy­ers

Am­gen, J&J’s Janssen and Sanofi are all in talks to ac­quire Hori­zon Ther­a­peu­tics, the rare dis­ease biotech dis­closed late Tues­day.

Hori­zon con­firmed “

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.